SHR-2004 clinical trials
How each study uses SHR-2004 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses SHR-2004 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee ArthroplastyCompletedPhase 3Beijing Suncadia Pharmaceuticals Co., LtdNCT06825416Written as SHR-2004 injection
- Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial FibrillationCompletedPhase 1Beijing Suncadia Pharmaceuticals Co., LtdNCT06280768Written as SHR-2004 injection
- A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer SurgeryCompletedPhase 2Beijing Suncadia Pharmaceuticals Co., LtdNCT06220123Written as SHR-2004
- SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee ArthroplastyCompletedPhase 2Beijing Suncadia Pharmaceuticals Co., LtdNCT05752461Written as SHR-2004 injection